Literature DB >> 23726835

Slow growth and unstable ribosomal RNA lacking pseudouridine in mouse embryonic fibroblast cells expressing catalytically inactive dyskerin.

Bai-Wei Gu1, Jingping Ge, Jian-Meng Fan, Monica Bessler, Philip J Mason.   

Abstract

Pseudouridine is the most abundant modified nucleotide in ribosomal RNA throughout eukaryotes and archaea but its role is not known. Here we produced mouse embryonic fibroblast cells expressing only catalytically inactive dyskerin, the pseudouridine synthase that converts uridine to pseudouridine in ribosomal RNA. The mutant dyskerin protein, D125A, was extremely unstable but cells were able to divide and grow very slowly. Abnormalities in ribosome RNA synthesis were apparent but mature cytoplasmic RNAs lacking pseudouridine were produced and were very unstable. We conclude that pseudouridine is required to stabilize the secondary structure of ribosomal RNA that is essential for its function.
Copyright © 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23726835      PMCID: PMC3773870          DOI: 10.1016/j.febslet.2013.05.028

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  19 in total

1.  Dyskeratosis congenita fibroblasts are abnormal and have unbalanced chromosomal rearrangements.

Authors:  I Dokal; J Bungey; P Williamson; D Oscier; J Hows; L Luzzatto
Journal:  Blood       Date:  1992-12-15       Impact factor: 22.113

Review 2.  The box C/D and H/ACA snoRNPs: key players in the modification, processing and the dynamic folding of ribosomal RNA.

Authors:  Nicholas J Watkins; Markus T Bohnsack
Journal:  Wiley Interdiscip Rev RNA       Date:  2011-11-07       Impact factor: 9.957

Review 3.  Dyskeratosis congenita: a disorder of defective telomere maintenance?

Authors:  Amanda J Walne; Anna Marrone; Inderjeet Dokal
Journal:  Int J Hematol       Date:  2005-10       Impact factor: 2.490

4.  Point mutations in yeast CBF5 can abolish in vivo pseudouridylation of rRNA.

Authors:  Y Zebarjadian; T King; M J Fournier; L Clarke; J Carbon
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

5.  A conserved aspartate of tRNA pseudouridine synthase is essential for activity and a probable nucleophilic catalyst.

Authors:  L Huang; M Pookanjanatavip; X Gu; D V Santi
Journal:  Biochemistry       Date:  1998-01-06       Impact factor: 3.162

6.  Mouse dyskerin mutations affect accumulation of telomerase RNA and small nucleolar RNA, telomerase activity, and ribosomal RNA processing.

Authors:  Yuko Mochizuki; Jun He; Shashikant Kulkarni; Monica Bessler; Philip J Mason
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-07       Impact factor: 11.205

7.  An essential yeast protein, CBF5p, binds in vitro to centromeres and microtubules.

Authors:  W Jiang; K Middleton; H J Yoon; C Fouquet; J Carbon
Journal:  Mol Cell Biol       Date:  1993-08       Impact factor: 4.272

8.  U17/snR30 is a ubiquitous snoRNA with two conserved sequence motifs essential for 18S rRNA production.

Authors:  Vera Atzorn; Paola Fragapane; Tamás Kiss
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

9.  Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification.

Authors:  Davide Ruggero; Silvia Grisendi; Francesco Piazza; Eduardo Rego; Francesca Mari; Pulivarthi H Rao; Carlos Cordon-Cardo; Pier Paolo Pandolfi
Journal:  Science       Date:  2003-01-10       Impact factor: 47.728

10.  Impaired adipogenesis and lipolysis in the mouse upon selective ablation of the retinoid X receptor alpha mediated by a tamoxifen-inducible chimeric Cre recombinase (Cre-ERT2) in adipocytes.

Authors:  T Imai; M Jiang; P Chambon; D Metzger
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

View more
  7 in total

1.  Impaired Telomere Maintenance and Decreased Canonical WNT Signaling but Normal Ribosome Biogenesis in Induced Pluripotent Stem Cells from X-Linked Dyskeratosis Congenita Patients.

Authors:  Bai-Wei Gu; Marisa Apicella; Jason Mills; Jian-Meng Fan; Dara A Reeves; Deborah French; Gregory M Podsakoff; Monica Bessler; Philip J Mason
Journal:  PLoS One       Date:  2015-05-18       Impact factor: 3.240

2.  The dyskerin ribonucleoprotein complex as an OCT4/SOX2 coactivator in embryonic stem cells.

Authors:  Yick W Fong; Jaclyn J Ho; Carla Inouye; Robert Tjian
Journal:  Elife       Date:  2014-11-19       Impact factor: 8.140

Review 3.  snoRNPs: Functions in Ribosome Biogenesis.

Authors:  Sandeep Ojha; Sulochan Malla; Shawn M Lyons
Journal:  Biomolecules       Date:  2020-05-18

Review 4.  The role of m6A, m5C and Ψ RNA modifications in cancer: Novel therapeutic opportunities.

Authors:  Paz Nombela; Borja Miguel-López; Sandra Blanco
Journal:  Mol Cancer       Date:  2021-01-18       Impact factor: 27.401

Review 5.  The role of RNA modification in hepatocellular carcinoma.

Authors:  Qiang Feng; Dongxu Wang; Tianyi Xue; Chao Lin; Yongjian Gao; Liqun Sun; Ye Jin; Dianfeng Liu
Journal:  Front Pharmacol       Date:  2022-09-02       Impact factor: 5.988

6.  Mutation of EMG1 causing Bowen-Conradi syndrome results in reduced cell proliferation rates concomitant with G2/M arrest and 18S rRNA processing delay.

Authors:  Joy Armistead; Richard Hemming; Nehal Patel; Barbara Triggs-Raine
Journal:  BBA Clin       Date:  2014-05-29

7.  A ribosome-related signature in peripheral blood CLL B cells is linked to reduced survival following treatment.

Authors:  T Sbarrato; E Horvilleur; T Pöyry; K Hill; L C Chaplin; R V Spriggs; M Stoneley; L Wilson; S Jayne; T Vulliamy; D Beck; I Dokal; M J S Dyer; A M Yeomans; G Packham; M Bushell; S D Wagner; A E Willis
Journal:  Cell Death Dis       Date:  2016-06-02       Impact factor: 8.469

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.